Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder

Annals of the New York Academy of Sciences

Volumn 1071, Issue , 2006, Pages 184-202

  Vermetten, Eric ^a   Vythilingam, Meena ^b   Schmahl, Christian ^c   De Kloet, Carien ^a   Southwick, Steven M ^d,e   Charney, Dennis S ^f   Douglas Bremner, J ^g,h  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Challenge; Cortisol; HPA axis; Paroxetine; PTSD; SSRI; Stress

Indexed keywords

HYDROCORTISONE; PAROXETINE;

ADAPTATION SYNDROME; ADULT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; HEART RATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; LONG TERM CARE; MALE; MEDICAL ASSISTANT; POSTTRAUMATIC STRESS DISORDER; PROVOCATION TEST; SALIVA ANALYSIS; STRESS; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 33746390104     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1364.014     Document Type: Conference Paper

References (74)

1. BREMNER, J.D., J. LICINIO, A. DARNELL, et al. 1997. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 154: 624-629.
2. BAKER, D.G., S.A. WEST, W.E. NICHOLSON, et al. 1999. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 156: 585-588.
3. YEHUDA, R., M.H. TEICHER, R.L. TRESTMAN, et al. 1996. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry 40: 79-88.
4. BREMNER, J.D., M. VYTHILINGAM, G. ANDERSON, et al.2003. Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol. Psychiatry 54: 710-718.
5. MASON, J.W., E.L. GILLER, T.R. KOSTEN, et al. 1986. Urinary free-cortisol levels in posttraumatic stress disorder patients. J. Nerv. Ment. Dis. 174: 145-149.
6. YEHUDA, R., S.M. SOUTHWICK, G. NUSSBAUM, et al. 1990. Low urinary cortisol excretion in patients with posttraumatic stress disorder. J. Nerv. Ment. Dis. 178: 366-369.
7. YEHUDA, R., B. KAHANA, K. BINDER-BRYNES, et al. 1995. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 152: 982-986.
8. NEYLAN, T.C., N. SCHUFF, M. LENOCI, et al. 2003. Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol. Psychiatry 54: 1118-1121.
9. ROHLEDER, N., L. JOKSIMOVIC, J.M. WOLF & C. KIRSCHBAUM. 2004. Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 55: 745-751.
10. WESSA, M., N. ROHLEDER, C. KIRSCHBAUM & H. FLOR. 2006. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 31: 209-215.
11. MASON, J.W., E.L. GILLER, T.R. KOSTEN & L. HARKNESS. 1988. Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder. J. Nerv. Ment. Dis. 176: 498-502.
12. PITMAN, R.K. & S.P. ORR. 1990. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol. Psychiatry 27: 245-247.
13. LEMIEUX, A.M. & C.L. COE. 1995. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom. Med. 57: 105-115.
14. MAES, M., A. LIN, S. BONACCORSO, et al. 1998. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr. Scand. 98: 328-335.
15. THALLER, V., M. VRKLJAN, L. HOTUJAC & J. THAKORE. 1999. The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis. Coll. Antropol. 23: 611-619.
16. YOUNG, E.A. & N. BRESLAU. 2004. Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch. Gen. Psychiatry 61: 394-401.
17. LUNDIN, T. 1997. Naval rescue workers and post-traumatic stress syndrome. Relieving conversation made coping easier. Lakartidningen 94: 1204-1206.
18. SIEGEL, A.J. & J.A. CHU. 2002. Factitious anemia due to self-administered blood-letting in psychiatric patients. J. Nerv. Ment. Dis. 190: 788-789.
19. MAYOU, R.A., A. EHLERS & M. HOBBS. 2000. Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial. Br. J. Psychiatry 176: 589-593.
20. BAKER, D.G., N.N. EKHATOR, J.W. KASCKOW, et al.2005. Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 162: 992-994.
21. DE KLOET, C.S., E. VERMETTEN, E. GEUZE, et al. 2005. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J. Psychiatr. Res. 2005 Oct 6; [Epub ahead of print]
22. BREMNER, J.D., M. VYTHILINGAM, E. VERMETTEN, et al. 2003. Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse. Psychoneuroendocrinology 28: 733-750.
23. SMITH, M.A., J. DAVIDSON, J.C. RITCHIE, et al. 1989. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol. Psychiatry 26: 349-355.
24. RASMUSSON, A.M., D.S. LIPSCHITZ, S. WANG, et al. 2001. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol. Psychiatry 50: 965-977.
25. KELLNER, M., A. YASSOURIDIS, R. HUBNER, et al. 2003. Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide? Neuropsychobiology 47: 102-108.
26. KANTER, E.D., C.W. WILKINSON, A.D. RADANT, et al. 2001. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol. Psychiatry 50: 238-245.
27. YEHUDA, R., R.A. LEVENGOOD, J. SCHMEIDLER, et al. 1996. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 21: 1-16.
28. KELLNER, M., C. OTTE, A. YASSOURIDIS, et al. 2004. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings. Eur. Neuropsychopharmacol. 14: 337-339.
29. YEHUDA, R., S.M. SOUTHWICK, J.H. KRYSTAL, et al. 1993. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry 150: 83-86.
30. YEHUDA, R., D. BOISONEAU, M.T. LOWY & E.L. GILLER JR. 1995. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch. Gen. Psychiatry 52: 583-593.
31. STEIN, M.B., R. YEHUDA, C. KOVEROLA & C. HANNA. 1997. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol. Psychiatry 42: 680-686.
32. YEHUDA, R., S.L. HALLIGAN, R. GROSSMAN, et al. 2002. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol. Psychiatry 52: 393-403.
33. YEHUDA, R., S.L. HALLIGAN, J.A. GOLIER, et al. 2004. Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology 29: 389-404.
34. NEWPORT, D.J., C. HEIM, R. BONSALL, et al. 2004. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol. Psychiatry 55: 10-20.
35. YEHUDA, R., J.A. GOLIER, S.L. HALLIGAN, et al. 2004. The ACTH response to dexamethasone in PTSD. Am. J. Psychiatry 161: 1397-1403.
36. LINDLEY, S.E., E.B. CARLSON & M. BENOIT. 2004. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol. Psychiatry 55: 940-945.
37. ELZINGA, B.M., C.G. SCHMAHL, E. VERMETTEN, et al. 2003. Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology 28: 1656-1665.
38. MARSHALL, R.D., K.L. BEEBE, M. OLDHAM & R. ZANINELLI. 2001. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am. J. Psychiatry 158: 1982-1988.
39. TUCKER, P., R. ZANINELLI, R. YEHUDA, et al.2001. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J. Clin. Psychiatry 62: 860-868.
40. TUCKER, P., K.L. SMITH, B. MARX, et al. 2000. Fluvoxamine reduces physiologic reactivity to trauma scripts in posttraumatic stress disorder. J. Clin. Psychopharmacol. 20: 367-372.
41. NIKISCH, G., A.A. MATHE, A. CZERNIK, et al. 2005. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with s-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl.) 181: 751-760.
42. RINNE, T., E.R. DE KLOET, L. WOUTERS, et al. 2003. Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse. Neuropsychopharmacology 28: 126-132.
43. SPITZER, R. 1994. Structural Clinical Interview for DSMIV. New York State Psychiatric Institute. New York.
44. BLAKE, D.D., F.W. WEATHERS, L.M. NAGY, et al. 1995. The development of a clinician-administered PTSD scale. J. Trauma. Stress 8: 75-90.
45. BREMNER, J.D., E. VERMETTEN & C.M. MAZURE. 2000. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress. Anxiety 12: 1-12.
46. SEEMAN, T.E., B. SINGER & P. CHARPENTIER. 1995. Gender differences in patterns of HPA axis response to challenge: Macarthur studies of successful aging. Psychoneuroendocrinology 20: 711-725.
47. SEEMAN, T.E., L.F. BERKMAN, P.A. CHARPENTIER, et al. 1995. Behavioral and psychosocial predictors of physical performance: Macarthur studies of successful aging. J. Gerontol. A Biol. Sci. Med. Sci. 50: M177-M183.
48. YEHUDA, R., M.T. LOWY, S.M. SOUTHWICK, et al. 1991. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am. J. Psychiatry 148: 499-504.
49. LOPEZ, J.F., D.M. VAZQUEZ, D.T. CHALMERS & S.J. WATSON. 1997. Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann. N. Y. Acad. Sci. 836: 106-134.
50. VEENEMA, A.H., J.M. KOOLHAAS & E.R. DE KLOET. 2004. Basal and stress-induced differences in HPA axis, 5-HT responsiveness, and hippocampal cell proliferation in two mouse lines. Ann. N. Y. Acad. Sci. 1018: 255-265.
51. TROIANI, T.A. & R.T. BOLAND. 1992. Critical incident stress debriefing: keeping your flight crew healthy. J. Air Med.. Transp. 11: 21-24.
52. ARORA, R.C., C.G. FICHTNER, F. O'CONNOR & J.W. CRAYTON. 1993. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci. 53: 919-928.
53. FICHTNER, C.G., R.C. ARORA, F.L. O'CONNOR & J.W. CRAYTON. 1994. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response. Life Sci. 54: PL39-PL44.
54. WEIZMAN, R., N. LAOR, A. SCHUJOVITSKY, et al. 1996. Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. Psychiatry Res. 63: 143-150.
55. MAGUIRE, K., T. NORMAN, G. BURROWS, et al. 1998. Platelet paroxetine binding in post-traumatic stress disorder. Psychiatry Res. 77: 1-7.
56. SPIVAK, B., Y. VERED, E. GRAFF, et al. 1999. Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biol. Psychiatry 45: 840-845.
57. CICIN-SAIN, L., N. MIMICA, D. HRANILOVIC, et al. 2000. Posttraumatic stress disorder and platelet serotonin measures. J. Psychiatr. Res. 34: 155-161.
58. HONDIUS, A.J., L.H. VAN WILLIGEN, W.C. KLEIJN & H.M. VAN DER PLOEG. 2000. Health problems among Latin-American and middle-eastern refugees in the Netherlands: relations with violence exposure and ongoing sociopsychological strain. J. Trauma. Stress 13: 619-634.
59. HOLBROOK, T.L., D.B. HOYT, M.B. STEIN & W.J. SIEBER. 2001. Perceived threat to life predicts posttraumatic stress disorder after major trauma: risk factors and functional outcome. J. Trauma 51: 287-292. Discussion 292-293.
60. PIVAC, N., D. MUCK-SELER, M. SAGUD & M. JAKOVLJEVIC. 2002. Platelet serotonergic markers in posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 26: 1193-1198.
61. COHEN, E., R. DEKEL, Z. SOLOMON & T. LAVIE. 2003. Posttraumatic stress symptoms and fear of intimacy among treated and non-treated survivors who were children during the Holocaust Soc. Psychiatry Psychiatr. Epidemiol. 38: 611-617.
62. ROY-BYRNE, P., L. BERLINER, J. RUSSO, et al. 2003. Treatment preferences and determinants in victims of sexual and physical assault. J. Nerv. Ment. Dis. 191: 161-165.
63. HERR, A.S., A.F. TSOLAKIDOU, A. YASSOURIDIS, et al. 2003. Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology 78: 12-22.
64. VEDDER, H., I. WEISS, F. HOLSBOER & J.M. REUL. 1993. Glucocorticoid and mineralocorticoid receptors in rat neocortical and hippocampal brain cells in culture: characterization and regulatory studies. Brain Res. 605: 18-24.
65. PRZEGALINSKI, E. & B. BUDZISZEWSKA. 1993. The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett. 161: 215-218.
66. RAISON, C.L. & A.H. MILLER. 2003. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 160: 1554-1565.
67. YEHUDA, R., J.A. GOLIER, R.K. YANG & L. TISCHLER. 2004. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 55: 1110-1116.
68. RINNE, T., H.G. WESTENBERG, J.A. DEN BOER & W. VAN DEN BRINK. 2000. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol. Psychiatry 47: 548-556.
69. HEIM, C., D.J. NEWPORT, D. WAGNER, et al. 2002. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress. Anxiety 15: 117-125.
70. VERMETTEN, E., M. VYTHILINGAM, S.M. SOUTHWICK, et al. 2003. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 54: 693-702.
71. WUST, S., I.S. FEDERENKO, E.F. VAN ROSSUM, et al. 2005. Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors. Psychoneuroendocrinology 30: 199-211.
72. KIRSCHBAUM, C. & D. HELLHAMMER. 1989. Response variability of salivary cortisol under psychological stimulation. J. Clin. Chem. Clin. Biochem. 27: 237.
73. KIRSCHBAUM, C., B.M. KUDIELKA, J. GAAB, et al. 1999. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 61: 154-162.
74. KAJANTIE, E. & D.I. PHILLIPS. 2006. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31: 151-178.